1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Neuroprotection Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Free Anti-Inflammatory Agents
1.2.3 Radical Trapping Agents (Antioxidants)
1.2.4 Apoptosis Inhibitors
1.2.5 Glutamate Antagonists (Anti-Excitotoxic Agents)
1.2.6 Neurotrophic Factors (NTFs)
1.2.7 Stimulants
1.2.8 Metal Ion Chelators
1.2.9 Others
1.3 Market by Application
1.3.1 Global Neuroprotection Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Prevention
1.3.3 Treatment
1.4 Study Objectives
1.5 Years Considered 2 Global Growth Trends
2.1 Global Neuroprotection Market Perspective (2017-2028)
2.2 Neuroprotection Growth Trends by Region
2.2.1 Neuroprotection Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Neuroprotection Historic Market Size by Region (2017-2022)
2.2.3 Neuroprotection Forecasted Market Size by Region (2023-2028)
2.3 Neuroprotection Market Dynamics
2.3.1 Neuroprotection Industry Trends
2.3.2 Neuroprotection Market Drivers
2.3.3 Neuroprotection Market Challenges
2.3.4 Neuroprotection Market Restraints 3 Competition Landscape by Key Players
3.1 Global Top Neuroprotection Players by Revenue
3.1.1 Global Top Neuroprotection Players by Revenue (2017-2022)
3.1.2 Global Neuroprotection Revenue Market Share by Players (2017-2022)
3.2 Global Neuroprotection Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Neuroprotection Revenue
3.4 Global Neuroprotection Market Concentration Ratio
3.4.1 Global Neuroprotection Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Neuroprotection Revenue in 2021
3.5 Neuroprotection Key Players Head office and Area Served
3.6 Key Players Neuroprotection Product Solution and Service
3.7 Date of Enter into Neuroprotection Market
3.8 Mergers & Acquisitions, Expansion Plans 4 Neuroprotection Breakdown Data by Type
4.1 Global Neuroprotection Historic Market Size by Type (2017-2022)
4.2 Global Neuroprotection Forecasted Market Size by Type (2023-2028) 5 Neuroprotection Breakdown Data by Application
5.1 Global Neuroprotection Historic Market Size by Application (2017-2022)
5.2 Global Neuroprotection Forecasted Market Size by Application (2023-2028) 6 North America
6.1 North America Neuroprotection Market Size (2017-2028)
6.2 North America Neuroprotection Market Size by Type
6.2.1 North America Neuroprotection Market Size by Type (2017-2022)
6.2.2 North America Neuroprotection Market Size by Type (2023-2028)
6.2.3 North America Neuroprotection Market Share by Type (2017-2028)
6.3 North America Neuroprotection Market Size by Application
6.3.1 North America Neuroprotection Market Size by Application (2017-2022)
6.3.2 North America Neuroprotection Market Size by Application (2023-2028)
6.3.3 North America Neuroprotection Market Share by Application (2017-2028)
6.4 North America Neuroprotection Market Size by Country
6.4.1 North America Neuroprotection Market Size by Country (2017-2022)
6.4.2 North America Neuroprotection Market Size by Country (2023-2028)
6.4.3 U.S.
6.4.4 Canada 7 Europe
7.1 Europe Neuroprotection Market Size (2017-2028)
7.2 Europe Neuroprotection Market Size by Type
7.2.1 Europe Neuroprotection Market Size by Type (2017-2022)
7.2.2 Europe Neuroprotection Market Size by Type (2023-2028)
7.2.3 Europe Neuroprotection Market Share by Type (2017-2028)
7.3 Europe Neuroprotection Market Size by Application
7.3.1 Europe Neuroprotection Market Size by Application (2017-2022)
7.3.2 Europe Neuroprotection Market Size by Application (2023-2028)
7.3.3 Europe Neuroprotection Market Share by Application (2017-2028)
7.4 Europe Neuroprotection Market Size by Country
7.4.1 Europe Neuroprotection Market Size by Country (2017-2022)
7.4.2 Europe Neuroprotection Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries 8 Asia-Pacific
8.1 Asia-Pacific Neuroprotection Market Size (2017-2028)
8.2 Asia-Pacific Neuroprotection Market Size by Type
8.2.1 Asia-Pacific Neuroprotection Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Neuroprotection Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Neuroprotection Market Share by Type (2017-2028)
8.3 Asia-Pacific Neuroprotection Market Size by Application
8.3.1 Asia-Pacific Neuroprotection Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Neuroprotection Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Neuroprotection Market Share by Application (2017-2028)
8.4 Asia-Pacific Neuroprotection Market Size by Region
8.4.1 Asia-Pacific Neuroprotection Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Neuroprotection Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia 9 Latin America
9.1 Latin America Neuroprotection Market Size (2017-2028)
9.2 Latin America Neuroprotection Market Size by Type
9.2.1 Latin America Neuroprotection Market Size by Type (2017-2022)
9.2.2 Latin America Neuroprotection Market Size by Type (2023-2028)
9.2.3 Latin America Neuroprotection Market Share by Type (2017-2028)
9.3 Latin America Neuroprotection Market Size by Application
9.3.1 Latin America Neuroprotection Market Size by Application (2017-2022)
9.3.2 Latin America Neuroprotection Market Size by Application (2023-2028)
9.3.3 Latin America Neuroprotection Market Share by Application (2017-2028)
9.4 Latin America Neuroprotection Market Size by Country
9.4.1 Latin America Neuroprotection Market Size by Country (2017-2022)
9.4.2 Latin America Neuroprotection Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil 10 Middle East & Africa
10.1 Middle East & Africa Neuroprotection Market Size (2017-2028)
10.2 Middle East & Africa Neuroprotection Market Size by Type
10.2.1 Middle East & Africa Neuroprotection Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Neuroprotection Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Neuroprotection Market Share by Type (2017-2028)
10.3 Middle East & Africa Neuroprotection Market Size by Application
10.3.1 Middle East & Africa Neuroprotection Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Neuroprotection Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Neuroprotection Market Share by Application (2017-2028)
10.4 Middle East & Africa Neuroprotection Market Size by Country
10.4.1 Middle East & Africa Neuroprotection Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Neuroprotection Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE 11 Key Players Profiles
11.1 F. Hoffmann-La Roche
11.1.1 F. Hoffmann-La Roche Company Details
11.1.2 F. Hoffmann-La Roche Business Overview
11.1.3 F. Hoffmann-La Roche Neuroprotection Introduction
11.1.4 F. Hoffmann-La Roche Revenue in Neuroprotection Business (2017-2022)
11.1.5 F. Hoffmann-La Roche Recent Developments
11.2 Eli Lilly and Company
11.2.1 Eli Lilly and Company Company Details
11.2.2 Eli Lilly and Company Business Overview
11.2.3 Eli Lilly and Company Neuroprotection Introduction
11.2.4 Eli Lilly and Company Revenue in Neuroprotection Business (2017-2022)
11.2.5 Eli Lilly and Company Recent Developments
11.3 Daiichi Sankyo Company
11.3.1 Daiichi Sankyo Company Company Details
11.3.2 Daiichi Sankyo Company Business Overview
11.3.3 Daiichi Sankyo Company Neuroprotection Introduction
11.3.4 Daiichi Sankyo Company Revenue in Neuroprotection Business (2017-2022)
11.3.5 Daiichi Sankyo Company Recent Developments
11.4 Allergan
11.4.1 Allergan Company Details
11.4.2 Allergan Business Overview
11.4.3 Allergan Neuroprotection Introduction
11.4.4 Allergan Revenue in Neuroprotection Business (2017-2022)
11.4.5 Allergan Recent Developments
11.5 Novartis
11.5.1 Novartis Company Details
11.5.2 Novartis Business Overview
11.5.3 Novartis Neuroprotection Introduction
11.5.4 Novartis Revenue in Neuroprotection Business (2017-2022)
11.5.5 Novartis Recent Developments
11.6 AstraZeneca
11.6.1 AstraZeneca Company Details
11.6.2 AstraZeneca Business Overview
11.6.3 AstraZeneca Neuroprotection Introduction
11.6.4 AstraZeneca Revenue in Neuroprotection Business (2017-2022)
11.6.5 AstraZeneca Recent Developments
11.7 Dr. Reddy's Laboratories
11.7.1 Dr. Reddy's Laboratories Company Details
11.7.2 Dr. Reddy's Laboratories Business Overview
11.7.3 Dr. Reddy's Laboratories Neuroprotection Introduction
11.7.4 Dr. Reddy's Laboratories Revenue in Neuroprotection Business (2017-2022)
11.7.5 Dr. Reddy's Laboratories Recent Developments
11.8 Astrocyte Pharmaceuticals
11.8.1 Astrocyte Pharmaceuticals Company Details
11.8.2 Astrocyte Pharmaceuticals Business Overview
11.8.3 Astrocyte Pharmaceuticals Neuroprotection Introduction
11.8.4 Astrocyte Pharmaceuticals Revenue in Neuroprotection Business (2017-2022)
11.8.5 Astrocyte Pharmaceuticals Recent Developments
11.9 Teva Pharmaceutical Industries
11.9.1 Teva Pharmaceutical Industries Company Details
11.9.2 Teva Pharmaceutical Industries Business Overview
11.9.3 Teva Pharmaceutical Industries Neuroprotection Introduction
11.9.4 Teva Pharmaceutical Industries Revenue in Neuroprotection Business (2017-2022)
11.9.5 Teva Pharmaceutical Industries Recent Developments
11.10 Biogen
11.10.1 Biogen Company Details
11.10.2 Biogen Business Overview
11.10.3 Biogen Neuroprotection Introduction
11.10.4 Biogen Revenue in Neuroprotection Business (2017-2022)
11.10.5 Biogen Recent Developments 12 Analyst's Viewpoints/Conclusions 13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer
